Even though the exact molecular impact of changes in the ECM proteins during AD development is still under investigation, its effects on synaptic transmission, amyloid-β-plaque generation and degradation, Tau-protein production, oxidative stress response, and inflammatory response have been reviewed [59]. The gene discussed is MAPT; the disease is Alzheimer disease.